![[Joint Session] Welcoming Remarks and Keynote Session icon](https://opus-nc-public.digitellcdn.com/assets/img/ks/product_icons/1605937d431d3c.png){kind=icon}
[Joint Session] Welcoming Remarks and Keynote Session
Mar 22, 2021 9:00am ‐ Mar 22, 2021 10:10am
Co-Chair(s):
- Jay D. Horton, MD, University of Texas Southwestern Medical Center
- Alphonse E. Sirica, PhD, Virginia Commonwealth University
Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers
Mar 22, 2021 9:35am ‐ Mar 22, 2021 10:10am
Speaker(s):
- Hashem B. El-Serag, MD, Baylor College of Medicine
A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC
Mar 22, 2021 10:10am ‐ Mar 22, 2021 10:35am
Speaker(s):
- Lopa Mishra, MD, George Washington University
![[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers icon](https://opus-nc-public.digitellcdn.com/assets/img/ks/product_icons/16059d9c3d4f40.png){kind=icon}
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Mar 22, 2021 10:10am ‐ Mar 22, 2021 12:00pm
Co-Chair(s):
- Jay D. Horton, MD, University of Texas Southwestern Medical Center
- Alphonse E. Sirica, PhD, Virginia Commonwealth University
The Gut-Liver Axis in Liver Cancer Risk Conditions
Mar 22, 2021 10:55am ‐ Mar 22, 2021 11:20am
Speaker(s):
- Maria Rescigno, PhD, Humanitas University
Lipid Dysregulation in Inflammation, NASH, and Cancer
Mar 22, 2021 11:20am ‐ Mar 22, 2021 11:45am
Speaker(s):
- Daniel A. Heller, PhD, Memorial Sloan Kettering Cancer Center
Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study
Mar 22, 2021 11:45am ‐ Mar 22, 2021 12:00pm
Speaker(s):
- Juan R. Sanabria, MD, Marshall University/Case Western Reserve University
Role of Cancer Associated Fibroblasts in Cholangiocarcinoma
Mar 22, 2021 4:00pm ‐ Mar 22, 2021 4:30pm
Speaker(s):
- Silvia Affo, PhD, Columbia University
Tumor Microenvironment and Hepatobiliary Cancers
Mar 22, 2021 4:00pm ‐ Mar 22, 2021 7:10pm
Co-Chair(s):
- Lopa Mishra, MD, George Washington University
- Gregory J. Gores, MD, Mayo Clinic
Mechanisms of Immune Escape in Hepatocellular Carcinoma
Mar 22, 2021 4:30pm ‐ Mar 22, 2021 5:00pm
Speaker(s):
- Amaia Lujambio, PhD, Icahn School of Medicine at Mount Sinai